Assembly Biosciences, Inc. Increase (Decrease) in Other Current Assets
Assembly Biosciences, Inc. (ASMB) reported Increase (Decrease) in Other Current Assets of -$94.94 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2016-11-09
- Assembly Biosciences, Inc. increase (decrease) in other current assets for the quarter ending 2016-09-30 was $52.71K, a 47.36% decline year-over-year.
- Assembly Biosciences, Inc. increase (decrease) in other current assets for the quarter ending 2016-06-30 was -$209.04K, a 165.05% decline year-over-year.
- Assembly Biosciences, Inc. increase (decrease) in other current assets for the quarter ending 2016-03-31 was $61.39K, a 61.28% decline year-over-year.
- Assembly Biosciences, Inc. increase (decrease) in other current assets for the quarter ending 2015-12-31 was -$24.16K, a 317.44% decline year-over-year.
- Assembly Biosciences, Inc. increase (decrease) in other current assets for fiscal 2015 was $555.85K, a 920.43% increase from fiscal 2014.
- Assembly Biosciences, Inc. increase (decrease) in other current assets for fiscal 2014 was $54.47K, a 1232.49% increase from fiscal 2013.
- Assembly Biosciences, Inc. increase (decrease) in other current assets for fiscal 2013 was $4.09K.
- Assembly Biosciences, Inc. increase (decrease) in other current assets for fiscal 2012 was -$2.54K, a 105.89% decline from fiscal 2011.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month | Increase (Decrease) in Other Current Assets 69 month | Increase (Decrease) in Other Current Assets 72 month | Increase (Decrease) in Other Current Assets 75 month | Increase (Decrease) in Other Current Assets 78 month | Increase (Decrease) in Other Current Assets 81 month | Increase (Decrease) in Other Current Assets 84 month | Increase (Decrease) in Other Current Assets 87 month | Increase (Decrease) in Other Current Assets 90 month | Increase (Decrease) in Other Current Assets 93 month | Increase (Decrease) in Other Current Assets 96 month | Increase (Decrease) in Other Current Assets 99 month | Increase (Decrease) in Other Current Assets 102 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-09-30 | $52.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$156.33K derived: sum of 2 quarters · filed 2016-11-09 | -$94.94K 10-Q · filed 2016-11-09 | -$119.10K derived: sum of 4 quarters · filed 2016-11-09 | ||||||||||||
| 2016-06-30 | -$209.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$147.64K 10-Q · filed 2016-08-09 | -$171.81K derived: sum of 3 quarters · filed 2016-08-09 | -$71.67K derived: sum of 4 quarters · filed 2016-11-09 | ||||||||||||
| 2016-03-31 | $61.39K 10-Q · filed 2016-05-10 | $37.23K derived: sum of 2 quarters · filed 2016-05-10 | $137.37K derived: sum of 3 quarters · filed 2016-11-09 | $458.69K derived: sum of 4 quarters · filed 2016-11-09 | ||||||||||||
| 2015-12-31 | -$24.16K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $75.97K derived: sum of 2 quarters · filed 2016-11-09 | $397.30K derived: sum of 3 quarters · filed 2016-11-09 | $555.85K 10-K · filed 2016-03-11 | ||||||||||||
| 2015-09-30 | $100.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $421.46K derived: sum of 2 quarters · filed 2016-11-09 | $580.01K 10-Q · filed 2016-11-09 | $591.12K derived: sum of 4 quarters · filed 2016-11-09 | ||||||||||||
| 2015-06-30 | $321.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $479.88K 10-Q · filed 2016-08-09 | $490.99K derived: sum of 3 quarters · filed 2016-08-09 | $166.55K derived: sum of 4 quarters · filed 2016-08-09 | ||||||||||||
| 2015-03-31 | $158.55K 10-Q · filed 2016-05-10 | $169.66K derived: sum of 2 quarters · filed 2016-05-10 | -$154.78K derived: sum of 3 quarters · filed 2016-05-10 | $17.50K derived: sum of 4 quarters · filed 2016-05-10 | ||||||||||||
| 2014-12-31 | $11.11K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | -$313.33K derived: sum of 2 quarters · filed 2016-03-11 | -$141.05K derived: sum of 3 quarters · filed 2016-03-11 | $54.47K 10-K · filed 2016-03-11 | ||||||||||||
| 2014-09-30 | -$324.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$152.16K derived: sum of 2 quarters · filed 2015-11-09 | $43.36K 10-Q · filed 2015-11-09 | -$27.75K derived: sum of 4 quarters · filed 2015-11-09 | ||||||||||||
| 2014-06-30 | $172.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $367.80K 10-Q · filed 2015-08-13 | $296.69K derived: sum of 3 quarters · filed 2015-08-13 | $253.95K derived: sum of 4 quarters · filed 2015-08-13 | ||||||||||||
| 2014-03-31 | $195.52K 10-Q · filed 2015-05-08 | $124.41K derived: sum of 2 quarters · filed 2015-05-08 | $81.67K derived: sum of 3 quarters · filed 2015-05-08 | $35.54K derived: sum of 4 quarters · filed 2015-05-08 | $259.19K 10-Q · filed 2014-05-14 | |||||||||||
| 2013-12-31 | -$71.11K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$113.85K derived: sum of 2 quarters · filed 2015-03-16 | -$159.98K derived: sum of 3 quarters · filed 2015-03-16 | $4.09K 10-K · filed 2015-03-16 | $63.67K 10-K · filed 2014-03-31 | |||||||||||
| 2013-09-30 | -$42.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-17 | -$88.87K derived: sum of 2 quarters · filed 2014-11-17 | $75.20K 10-Q · filed 2014-11-17 | $23.60K derived: sum of 4 quarters · filed 2014-11-17 | $134.78K 10-Q · filed 2013-11-12 | |||||||||||
| 2013-06-30 | -$46.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $117.94K 10-Q · filed 2014-08-14 | $66.34K derived: sum of 3 quarters · filed 2014-08-14 | $20.44K derived: sum of 4 quarters · filed 2014-08-14 | $177.52K 10-Q · filed 2013-08-09 | |||||||||||
| 2013-03-31 | $164.07K 10-Q · filed 2014-05-14 | $112.47K derived: sum of 2 quarters · filed 2014-05-14 | $66.56K derived: sum of 3 quarters · filed 2014-05-14 | -$34.80K derived: sum of 4 quarters · filed 2014-05-14 | $223.65K 10-Q · filed 2013-05-10 | |||||||||||
| 2012-12-31 | -$51.60K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$97.50K derived: sum of 2 quarters · filed 2014-03-31 | -$198.87K derived: sum of 3 quarters · filed 2014-03-31 | -$2.54K 10-K · filed 2014-03-31 | $59.58K 10-K · filed 2013-03-18 | |||||||||||
| 2012-09-30 | -$45.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$147.27K derived: sum of 2 quarters · filed 2013-11-12 | $49.05K 10-Q · filed 2013-11-12 | $26.20K derived: sum of 4 quarters · filed 2013-11-12 | $111.18K 10-Q · filed 2012-11-13 | |||||||||||
| 2012-06-30 | -$101.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $94.96K 10-Q · filed 2013-08-09 | $72.10K derived: sum of 3 quarters · filed 2013-08-09 | $59.98K derived: sum of 4 quarters · filed 2013-08-09 | $157.09K 10-Q · filed 2012-08-09 | |||||||||||
| 2012-03-31 | $196.32K 10-Q · filed 2013-05-10 | $173.47K derived: sum of 2 quarters · filed 2013-05-10 | $161.35K derived: sum of 3 quarters · filed 2013-05-10 | $156.92K derived: sum of 4 quarters · filed 2013-05-10 | $258.45K 10-Q · filed 2012-05-09 | |||||||||||
| 2011-12-31 | -$22.85K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$34.98K derived: sum of 2 quarters · filed 2013-03-18 | -$39.40K derived: sum of 3 quarters · filed 2013-03-18 | $43.21K 10-K · filed 2013-03-18 | $62.13K 10-K · filed 2012-03-14 | |||||||||||
| 2011-09-30 | -$12.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | -$16.55K derived: sum of 2 quarters · filed 2012-11-13 | $66.07K 10-Q · filed 2012-11-13 | $80.96K derived: sum of 4 quarters · filed 2013-03-18 | $84.98K 10-Q/A · filed 2011-11-18 | |||||||||||
| 2011-06-30 | -$4.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $78.19K 10-Q · filed 2012-08-09 | $93.08K derived: sum of 3 quarters · filed 2013-03-18 | $91.57K derived: sum of 4 quarters · filed 2013-03-18 | $97.11K 10-Q · filed 2011-08-15 | |||||||||||
| 2011-03-31 | $82.62K 10-Q · filed 2012-05-09 | $97.51K derived: sum of 2 quarters · filed 2013-03-18 | $96.00K derived: sum of 3 quarters · filed 2013-03-18 | |||||||||||||
| 2010-12-31 | $14.89K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-18 | $13.38K derived: sum of 2 quarters · filed 2013-03-18 | $16.40K 10-K · filed 2013-03-18 | |||||||||||||
| 2010-09-30 | -$1.51K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2011-11-18 | $1.51K 10-Q/A · filed 2011-11-18 | ||||||||||||||
| 2010-06-30 | $3.02K 10-Q · filed 2011-08-15 | |||||||||||||||
| 2009-12-31 | -$2.65K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |